Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.
To understand the molecular basis for hemophilia B in patients with little or no circulating Factor IX antigen, a patient who had less than 0.2% circulating Factor IX antigen (Factor IXSeattle 2) was selected for analysis of his Factor IX gene. Genomic DNA fragments from the abnormal gene were clone...
שמור ב:
| הוצא לאור ב: | J Clin Invest |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical Investigation
1987
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113155 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|